-
A preprint, non-peer-reviewed study states that weight-loss drugs such as Wegovy are more likely to cause temporary hair loss compared to Contrave. The latter is not overly efficacious hence less weight loss therefore less hair loss.
Medical Mythbusting Commentary for March 18, 2025 Source:Weight-Loss Drugs Like Wegovy Are Linked to Hair Loss Reference:Risk of Hair Loss with Semaglutide for Weight Loss
-
The promotion of testosterone replacement as men age is a Pharma-industry-created problem. Most men do not need it. Blood tests can determine the true state of testosterone levels and if abnormally low, treated.
Medical Mythbusting Commentary for March 13, 2025 Source:Testosterone therapy’s popular in the online ‘manosphere’ — but doctor warns it’s not for everyone
-
Researchers have found a genetic mutation for hypothyroidism that applies to 1/5000 people and that can lead to increased weight gain. Claims that it is a genetic link to obesity requires some jumping of the hoops.
Medical Mythbusting Commentary for June 25, 2024 Source:Researchers have found a ‘clear genetic trigger for obesity’ that applies to some people Reference: SMIM1 absence is associated with reduced energy expenditure and excess weight
-
Polycystic ovary syndrome seems to respond to the malaria drug artemisinin. Small study but more to come.
Medical Mythbusting Commentary for June 14, 2024 Source:Polycystic ovary syndrome could be treated with a malaria drug
-
Observational study looked at the relationship between the vasomotor symptoms (hot flushes) of menopause symptoms and migraine history and how it may increase the risk of cardiovascular disease for certain groups
Medical Mythbusting Commentary for April 17, 2024 Source:How menopause symptoms may increase the risk of cardiovascular disease
-
GLP-1 receptor agonist lixisenatide may help slow the progression of Parkinson’s symptoms
Medical Mythbusting Commentary for April 10, 2024 Source:Ozempic-like drug may help slow the progression of Parkinson’s symptoms Reference:Trial of Lixisenatide in Early Parkinson’s Disease
-
Small pilot study shows ketogenic diet reduces medication-related metabolic syndrome changes for people being treated for Schizophrenia and Bipolar Disorder
Medical Mythbusting Commentary for April 4, 2024 Source:Pilot study shows ketogenic diet improves severe mental illness Reference:Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial
-
Initial small studies show that the use of Semaglutide (Ozempic) may help reduce alcohol consumption.
Medical Mythbusting Commentary for December 4, 2023 Source:Ozempic Could Also Help You Drink Less Alcohol